Hyphema

02/01/1991 - "We concluded that although the use of tissue plasminogen activator in our rabbit model of traumatic hyphema significantly improved clearance of blood from the anterior chamber, the remaining clot was of such size that the clinical benefit was questionable."
02/01/1991 - "Tissue plasminogen activator was used to evaluate the clearance of traumatic hyphema in a rabbit model. "
02/01/1990 - "Tissue plasminogen activator has recently been shown to enhance the clearance of experimental nontraumatic hyphema in animals. "
12/01/2000 - "to evaluate the efficacy and the safety of low dose intraocular tissue plasminogen activator (rt-PA) in the treatment of traumatic hyphema and postoperative fibrinous membrane. "
09/01/1998 - "Treatment of total hyphema with relatively low-dose tissue plasminogen activator."

09/01/2008 - "The correlations between the development of CD and postoperative findings such as shallowing of the anterior chamber, hypotony, hypotonic maculopathy, hyphema, and fibrin reaction in the anterior chamber were statistically significant.CD was not associated with a significant reduction of BCVA. "
11/01/2010 - "This finding implies that the prevention of hyphema and fibrin formation based on the slit-lamp examination can not be predicted, even if neovascularization in iris surface seems to be eliminated by a single dose of IVB."
02/01/2012 - "Early posttreatment complications included hyphema, fibrin's exudation, chemosis. "
01/01/2012 - "To describe the technique for the removal of bulky fibrin in persistent traumatic full hyphema by using anterior chamber maintainer (ACM). "
11/01/2010 - "The frequency of hyphema and fibrin formation in the anterior chamber 1 day after surgery between the two NVG groups was not statistically significant. "

11/01/2003 - "To determine the safety and efficacy of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema. "
11/01/2003 - "This study provides evidence that topical aminocaproic acid is safe and demonstrates trends towards reducing the rebleeding rate in the management of traumatic hyphema. "
01/01/2013 - "However, hyphema in patients treated with aminocaproic acid take longer to clear.Other"
01/01/2013 - "The number of days for the primary hyphema to resolve appeared to be longer with the use of aminocaproic acid compared with no use, but was not altered by any other intervention.Systemic"
01/01/2011 - "However, hyphema in patients on aminocaproic acid take longer to clear.Other"

11/01/2002 - "To report the characteristics and functional outcome of patients with traumatic hyphema and to discuss possible recommendations regarding the use of epsilon-aminocaproic acid. "
11/01/2002 - "Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid."
09/01/1997 - "The treatment of traumatic hyphema with topical epsilon-aminocaproic acid."
11/01/1990 - "Epsilon aminocaproic acid (EACA) is an antifibrinolytic agent currently used in the management of traumatic hyphema. "
11/01/1990 - "[Epsilon aminocaproic acid for management of traumatic hyphema with large blood clot in the anterior chamber]."

06/01/1999 - "The clearance of hyphemas in the melanin-treated eyes was significantly prolonged throughout the study (P<.001). "
06/01/1999 - "The presence of melanin results in a significantly prolonged course of hyphemas and may influence the rate of rebleeds. "
06/01/1999 - "Hyphemas were consistently produced in all eyes with mean+/-SD levels of 1.44+/-0.22 mm and 1.57+/-0.24 mm in the melanin-treated and control eyes, respectively. "
06/01/1999 - "Effect of melanin on traumatic hyphema in rabbits."
06/01/1999 - "The release of melanin into the anterior chamber during ocular trauma may be partly responsible for the susceptibility of darker-pigmented individuals to more serious complications following a traumatic hyphema."

03/01/2014 - "We sought to determine the efficacy of topical tranexamic acid (5%) in the management of traumatic hyphema. "
03/01/2014 - "Topical tranexamic acid seems promising in the management of traumatic hyphema. "
03/01/2014 - "The patients were also compared with two historical control groups of patients (80 eyes) with traumatic hyphema; the first control group was treated with oral placebo and the other group was treated with oral tranexamic acid at our department. "
03/01/2014 - "Comparison between Topical and Oral Tranexamic Acid in Management of Traumatic Hyphema."
08/01/2008 - "Tranexamic acid in the treatment of pediatric traumatic hyphema."

05/01/1993 - "Recurrent hyphema associated with IOL loop displacement treated with argon laser photocoagulation."
04/01/1992 - "We studied several commonly encountered clinical situations which may affect the trabecular meshwork: phagocytosis of debris, hyphema, and argon laser trabeculoplasty. "
10/01/1984 - "Delayed hyphema after argon laser iridectomy."
03/01/2005 - "Argon laser treatment of symptomatic iris vascular tufts promotes resolution of recurrent, spontaneous hyphema and may serve to mitigate the risk of hemorrhage from these lesions during subsequent intraocular surgery. "
05/01/1986 - "Argon laser therapy of occult recurrent hyphema from anterior segment wound neovascularization."

04/01/1987 - "[Treatment of traumatic recurrent hyphema with sodium hyaluronate]."
01/01/1986 - "The only definite benefit noted with the use of sodium hyaluronate was the lower incidence of hyphemas. "
11/01/1981 - "Surgical management of black ball hyphema with sodium hyaluronate."
07/01/2006 - "Sodium hyaluronate-assisted trabeculectomy decreased the incidence of early postoperative complications like anterior chamber shallowing, choroidal detachment and hypotony, but it did not have any effect on hyphema or its clearance."
06/15/1986 - "Sodium hyaluronate, hyphema, and vitreoretinal surgery."

09/01/1981 - "In the citrate-treated eyes there was a significantly reduced incidence of band keratopathy (17%) but an increased incidence of hyphema (100%). "

01/01/1994 - "The authors demonstrate the tPA eye drops administered to patients with postoperative hyphema, which did not respond to traditional therapy, gave rapid clearance of the clot. "

10/01/2014 - "One patient in the sutureless trabeculectomy group developed mild hyphema which was managed medically. "
06/01/2014 - "The risk factors for hyphema after trabeculectomy with MMC are independently associated with NVG and anticoagulant or antiplatelet medication. "
06/01/2014 - "Of the 108 NVG patients, 43 (39.8%) had hyphema after trabeculectomy with MMC. "
01/01/2014 - "There was no significant association between preoperative IVB and postoperative hyphema or the results of trabeculectomy."
01/01/2014 - "Postoperative hyphema was significantly correlated with the outcome of trabeculectomy for NVG. "

07/01/2010 - "All eyes developed post-laser hyphema, 3 with elevated intraocular pressure. "
02/01/2010 - "Anterior chamber hyphema in the laser group was milder than that in the surgery group, and disappeared on the third day. "
06/01/1982 - "Hyphema complicating laser iridotomy."
06/01/2010 - "We report the first case of iris vascular tuft (Cobb's tuft) causing recurrent spontaneous hyphema and raised intraocular pressure that underwent laser photocoagulation (LaP). "
06/01/2010 - "Iris vascular tuft causing recurrent hyphema and raised IOP: a new indication for laser photocoagulation, angiographic follow-up, and review of laser outcomes."

06/01/1993 - "Hyphema as a complication of adjustable suture surgery."
06/01/2000 - "Perforations occurred during muscle reattachment (5 cases), placement of traction sutures at the limbus (4 cases with transient hyphema), muscle disinsertion (3 cases), and placement of sutures at the muscle insertion before disinsertion (3 cases). "
06/01/1997 - "In 17 eyes that had surgery using this technique, mean postoperative visual acuity was 20/25; complications included irregular pupil, iris capture, pupil block, hyphema, localized peripheral anterior synechia, IOL tilt, suture exposure, and cystoid macular edema."
06/01/2013 - "The complications were 2 microruptures of the trabeculodescemetic window, 5 entries in the collector channels, 5 choroidal space/anterior chamber passages, 10 hyphemas, 3 hypotonies, one peripheral Descemet detachment, one intracorneal hematoma, two peripheral anterior synechia, one internal iris prolapse, and two suture extrusions to the anterior chamber. "
06/01/1991 - "The transscleral suture fixation-related complications included vitreous hemorrhage, hyphema and retinal detachment."

06/01/2010 - "We report the first case of iris vascular tuft (Cobb's tuft) causing recurrent spontaneous hyphema and raised intraocular pressure that underwent laser photocoagulation (LaP). "
06/01/2010 - "Iris vascular tuft causing recurrent hyphema and raised IOP: a new indication for laser photocoagulation, angiographic follow-up, and review of laser outcomes."
08/01/1999 - "Photocoagulation of the surface of an iris nevus may prevent recurrent hyphema."
08/01/1999 - "Before photocoagulation of the iris nevus, the patient had increasing frequency of hyphema episodes. "
08/01/1999 - "In a 30-year-old woman with recurrent hyphema secondary to an iris nevus, photocoagulation was applied to the iris nevus. "

08/01/1994 - "As complications, corneal fold formation (all eyes), choroidal detachment (12 eyes), hyphema (10 eyes), and iris incarceration in the sclerostomy site (4 eyes) were found. "
01/01/1995 - "Postoperatively, reversible adherence of the iris to the internal ostium was more frequently observed in Ho:YAG laser sclerostomies (60%) and small hyphemas were more often seen in Er:YAG laser sclerostomies (30%). "
01/01/1976 - "In our cataract/thermal sclerostomy group, 61% had improvement in visual acuity, 61% had normalization of intraocular pressures without antiglaucoma medications, 17% had transient postoperative hyphemas. "
11/01/1996 - "Complications included serous choroidal detachment (10 eyes), suprachoroidal hemorrhage (1 eye), bleb leak (5 eyes), iris blocking sclerostomy (2 eyes), hyphema (2 eyes), corneal abrasion (2 eyes), and hypotony (1 eye). "
05/01/1994 - "Complications may be seen with the THC-YAG sclerostomy and include: conjunctival burn, filtration bleb leak, posterior corneal striae, peaked pupil, iris incarceration, infection, hyphema, cataracts and ocular hypotony. "